Thrivent Financial For Lutherans Invitae Corp Transaction History

Thrivent Financial For Lutherans

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$2.13 - $9.01 $1.01 Million - $4.26 Million	473,151 Added 747.08%	536,484 $1.31 Million
Q1 2022 May 13, 2022	BUY	$6.28 - $15.59 $397,731 - $987,361	63,333 New	63,333 $505,000
Q4 2021 Feb 16, 2022	SELL	$14.7 - $28.67 $104,649 - $204,101	-7,119 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $173,062 - $239,198	7,119 New	7,119 $202,000
Q2 2021 Aug 19, 2021	SELL	$26.09 - $40.4 $1.87 Million - $2.9 Million	-71,714 Closed	0 $0

Q1 2021 May 17, 2021	SELL	$33.06 - $56.93 $289,837 - $499,105	-8,767 Reduced 10.89%	71,714 $2.74 Million
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $10,124 - $14,866	259 Added 0.32%	80,481 $3.37 Million
Q3 2020 Nov 10, 2020	BUY	$28.43 - $44.67 $1.35 Million - $2.11 Million	47,311 Added 143.75%	80,222 $3.48 Million
Q2 2020 Aug 12, 2020	BUY	$11.71 - $30.29 $108,739 - $281,272	9,286 Added 39.31%	32,911 $997,000
Q1 2020 May 15, 2020	BUY	$7.64 - $27.5 $180,495 - $649,687	23,625 New	23,625 $323,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.